Clinical Trials Logo

Pleural Effusion clinical trials

View clinical trials related to Pleural Effusion.

Filter by:

NCT ID: NCT04131231 Not yet recruiting - Breast Cancer Clinical Trials

Safety and Effectiveness of MPCD Therapy on the Treatment of Malignant Pleural Effusion

Start date: October 15, 2019
Phase: N/A
Study type: Interventional

This is a prospective, open-label , multicenter randomized controlled trial, with 248 cases in 50 centers planned for a period of 2 years. The aim of the study is to evaluate the safety and effectiveness of microparticles packaging chemotherapeutic drugs (MPCD) therapy on the treatment of malignant pleural effusion (MPE) in patients with advanced lung cancer or breast cancer.

NCT ID: NCT04074902 Not yet recruiting - Pleurodesis Clinical Trials

Role of Chest Sonography in Evaluation of Pleurodesis in Patients With Malignant Pleural Effusion

Start date: September 2019
Phase:
Study type: Observational

Thoracic ultrasonography easily detects the movement of the visceral pleura on the parietal pleura This sign is absent when pleurodesis is successful.

NCT ID: NCT03781908 Not yet recruiting - Clinical trials for Pleural Effusion, Malignant

Management of Malignant Pleural Effusion With Indwelling Pleural Catheter Versus Silver Nitrate Pleurodesis

Start date: January 1, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

The primary goal of this study is to compare well-defined pleural effusion management success outcomes in patients with malignant or paramalignant pleural effusions who were treated with Indwelling pleural catheter insertion compared with those treated with siver nitrate pleurodesis. It is also to demonstrate the effectiveness of silver nitrate pleurodesis. It is also important to evaluate frequent adverse events of silver nitrate pleurodesis in patients with malignant pleural effusion

NCT ID: NCT03736122 Not yet recruiting - Clinical trials for Malignant Pleural Effusion

A Study of Syngenon (BSG-001) for Inhalation in Subjects With Malignant Pleural Effusion and/or Malignant Ascites

Start date: January 2019
Phase: Phase 1/Phase 2
Study type: Interventional

Malignant pleural effusion and/ or malignant ascites is generally defined by presence of malignant cells in the effusion fluid. The first-line therapies are mostly intrusive, medically demanding and inefficient, and therefore, it is important to study and develop new therapeutic option to address the unmet need. This protocol for BSG-001 is developed for the treatment of malignant pleural effusion and/ or malignant ascites. BSG-001 is an immune-modulator primarily exerts its effect via Toll-like receptor. The purpose of this study is to assess the safety and tolerability of BSG-001. All eligible subjects will receive BSG-001 for at least 12 weeks (3 cycles).

NCT ID: NCT03716375 Not yet recruiting - Clinical trials for Complicated Pleural Effusion/ Empyema

Efficacy of Fibrinolytic Agents in Complicated Pleural Effusion

Start date: November 2018
Phase: N/A
Study type: Interventional

Intrapleural administration of fibrinolytic therapy, urokinase in parapneumonic effusion and empyema has been shown to decrease the need for surgical intervention and length of hospital stay. Pleural adhesions are easily formed in the early stages of empyema and the thickening of the pleural causes subsequent treatment difficulties. The goal of this study was to observe and compare the efficacy of treatment in empyema patients with urokinase and chest drainage or with chest drainage or with chest tube drainage alone so as to provide evidence for guiding clinical treatment.

NCT ID: NCT03480490 Not yet recruiting - Pleural Effusion Clinical Trials

Evaluation and Outcome of Para-pneumonic Effusion

Start date: January 1, 2019
Phase:
Study type: Observational

Pleural effusion is the accumulation of excess fluid in the pleural cavity, which results in disturbance of the equilibrium between vascular hydrostatic and oncotic pressures. The underlying causes of pleural effusion include pleural inflammation or infection, congestive heart failure, lymphatic drainage blockage and malignancy.A parapneumonic effusion is a pleural effusion associated with lung infection. Early in the course of parapneumonic effusion, the pleura becomes inflamed with leakage of cellular elements, protein, and fluid into the pleural space, forming the effusion. Subsequent bacterial invasion results in a frank empyema, the presence of which often requires thoracentesis.

NCT ID: NCT03260088 Not yet recruiting - Pleural Effusion Clinical Trials

Evaluation Of Pleural Effusion At Assiut University Hospital

Start date: October 30, 2017
Phase: N/A
Study type: Observational

Pleural effusion is an accumulation of fluid between the tissue layers that line the lungs and chest cavity. It has an estimated prevalence of 320 per 100,000 people in industrialized countries. The cause of the pleural effusion remains unclear in a substantial percentage of patients with persistently exudative effusions.

NCT ID: NCT03172052 Not yet recruiting - Pleural Effusion Clinical Trials

Evaluating Different Modalities for Pleural Adhesiolysis at Assuit University Hospital

Start date: August 1, 2017
Phase: Phase 4
Study type: Interventional

interventional randomized clinical trial will be done at Assuit University Hospital ( Chest Department and Caridothoracic surgery department ),and all patients presented with complex septate pleural effusion in whom the symptoms excepted to be relieved by pleural fluid drainage will be included in our study within the two next years.

NCT ID: NCT02825095 Not yet recruiting - Lung Neoplasms Clinical Trials

Management of Malignant Pleural Effusion - Indwelling Pleural Catheter or Talc Pleurodesis

Start date: August 2016
Phase: Phase 0
Study type: Interventional

Prospective study of the effect of Talc Pleurodesis vs. Indwelling Pleural catheter in treatment of patients with malignant pleural effusion

NCT ID: NCT02805062 Not yet recruiting - Clinical trials for Pleural Effusion, Malignant

Manometry vs Clinical Assessment in the Detection of Trapped Lung in Patients With Suspected Pleural Malignancy

MASCOT
Start date: June 2016
Phase: N/A
Study type: Observational

Malignant pleural effusion is a common clinical problem with median survival of approximately 6 months thus efficient management of Malignant pleural effusion is important. In patients with a Trapped Lung, pleurodesis will be unsuccessful and an indwelling pleural catheter should be inserted instead. Accurate detection of Trapped Lung prior to insertion would avoid futile attempts at talc pleurodesis, re-intervention following failed pleurodesis and allow adequate time to plan for an indwelling pleural catheter insertion.Pleural manometry allows direct and objective measurement of intra-pleural pressure during pleural fluid aspiration.The primary aim of this study is to determine whether the addition of digital pleural manometry to clinical judgment, prior to and during local anaesthetic thoracoscopy, results in a clinically meaningful improvement in Trapped Lung detection.